Skip to main content

Table 1 Frequency of HGV RNA, Anti E2, HBsAg, HbcAB, HCV RNA and Anti HCV in patients and controls.

From: Hepatitis G virus infection in Egyptian children with chronic renal failure (single centre study)

 

HGV Exposure

HGV/RNA

Anti E2

HbsAg

HBcAB

HCV RNA

Anti HCV

Haemodialysis(34)

Predialysis (66)

23(67.6%)

28(42.4%)

9 (26.5%)

9 (13.6%)

14 (41.2%)

19 (28.8%)

2 (5.9%)

3 (4.5%)

2 (5.9%)

3 (4.5%)

33 (97%)

25 (37.9%)

32 (94.1%)

20 (30.3%)

Total (100)

51 (51%)

18 (18%)

33 (33%)

5 (5%)

5 (5%)

58 (58%)

52 (52%)

Controls (25)

2 (8%)

1 (4%)

1 (4%)

0

0

0

0